22nd Century Group, Inc. (XXII) Insider Trading Activity

NASDAQ$2.21+0.23 (11.62%)
Market Cap
$330,486.00
Sector
Consumer Defensive
Industry
Tobacco
Rank in Sector
171 of 173
Rank in Industry
7 of 7

XXII Insider Trading Activity

XXII Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About 22nd Century Group, Inc.

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Insider Activity of 22nd Century Group, Inc.

Over the last 12 months, insiders at 22nd Century Group, Inc. have bought $0 and sold $0 worth of 22nd Century Group, Inc. stock.

On average, over the past 5 years, insiders at 22nd Century Group, Inc. have bought $37,582 and sold $591,273 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 39,000 shares for transaction amount of $10,468 was made by FIRESTONE LAWRENCE (Chief Executive Officer) on 2024‑09‑12.

List of Insider Buy and Sell Transactions, 22nd Century Group, Inc.

2024-09-12PurchaseFIRESTONE LAWRENCEChief Executive Officer
39,000
0.4192%
$0.27
$10,468
-94.91%
2024-05-30PurchaseFIRESTONE LAWRENCEChief Executive Officer
9,000
0.1152%
$1.09
$9,829
-91.26%
2024-01-05PurchaseArno Andrewdirector
100,000
0.2224%
$0.17
$17,490
-74.93%
2024-01-04PurchaseFIRESTONE LAWRENCEChief Executive Officer
100,000
0.2334%
$0.17
$17,360
-73.77%
2022-08-31SaleZERCHER MICHAELPresident and COO
370,789
0.1778%
$1.35
$500,565
-86.19%
2022-06-14SaleFRANZINO JOHNChief Administrative Officer
20,324
0.0111%
$1.69
$34,443
+28.82%
2021-12-14SaleZERCHER MICHAELPresident and COO
23,147
0.0142%
$2.16
$50,037
+14.98%
2021-09-30PurchaseMISH JAMES AChief Executive Officer
20,000
0.012%
$2.88
$57,600
-15.71%
2021-06-10SaleFLEET CLIFFORD Bdirector
125,000
0.0835%
$4.78
$597,500
-33.55%
2021-03-31PurchaseMISH JAMES AChief Executive Officer
15,000
0.0095%
$3.23
$48,450
+33.89%
2021-03-17SaleSANDERS RICHARD M.director
47,227
0.031%
$2.72
$128,457
+53.48%
2021-03-16PurchaseO'BRIEN ROGER Ddirector
52,400
0.0368%
$2.86
$149,864
+56.21%
2020-11-17PurchaseMISH JAMES AChief Executive Officer
100,000
0.0637%
$0.93
$92,800
+255.24%
2020-06-29PurchaseSULLIVAN NORA Bdirector
22,000
0.0159%
$0.78
$17,160
+369.03%
2020-06-05PurchaseSULLIVAN NORA Bdirector
29,953
0.0224%
$0.82
$24,561
+338.91%
2020-06-04PurchaseSULLIVAN NORA Bdirector
71,372
0.0528%
$0.82
$58,661
+333.64%
2019-08-27PurchaseFLEET CLIFFORD BPresident and CEO
75,000
0.0607%
$1.88
$140,798
-41.89%
2019-08-26PurchaseFLEET CLIFFORD BPresident and CEO
25,000
0.0203%
$1.97
$49,250
-44.30%
2019-06-17SaleJAMES THOMAS L.VP, General Counsel & Sec'y.
48,000
0.0374%
$2.11
$101,198
-49.77%
2018-06-29SaleJAMES THOMAS L.VP, General Counsel & Sec'y.
50,000
0.0399%
$2.44
$121,925
+1.63%
Total: 178

XXII Institutional Investors: Active Positions

Increased Positions10+166.67%53,642+330.23%
Decreased Positions2-33.33%9,686-59.63%
New Positions8New8,549New
Sold Out Positions2Sold Out9,686Sold Out
Total Postitions14+133.33%60,200+270.6%

XXII Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.